Two product families, two intended roles

The current VSL website distinguishes VSL#3 medical foods from VSL4 dietary supplements. VSL#3 capsules are presented for dietary management of IBS and ulcerative colitis, while VSL4 Gut is presented for daily digestive support. Keeping the product family intact prevents a medical-food headline, clinical history, or cold-chain claim from being transferred to a newer wellness formula bearing a similar brand name.

The quantities and formats differ greatly

VSL#3 capsules are shown at 112.5 billion CFU, regular powder at 450 billion, and DS powder at 900 billion. The site says VSL#3 contains eight complementary strains from three genera. VSL4 Gut capsules instead list 30 billion CFU. The captured homepage does not expose full strain codes or the serving denominator for every variant, so those panels must be obtained separately.

Refrigerated versus shelf-stable handling

The company describes refrigerated production, storage, and shipping for VSL#3 and shelf stability with acid-resistant capsules for VSL4. It promises labeled potency through expiry when stored as recommended. Those are specific conditional company statements, not independent verification of a shipment’s temperature or a bottle’s live count. Someone choosing a room-temperature routine should not accidentally select the refrigerated medical-food line.

Legacy is not proof of identical formulations

The site invokes the research heritage of VSL#3 while expanding into VSL4 products. A historical study needs its formulation, manufacturer, strain identifiers, and date checked before being attached to a current product. We do not equate VSL#3 and Visbiome simply from an old publication title or the same nominal CFU number, and we do not transfer medical-food evidence to VSL4 Gut.

Choose the category before comparing the price

The page shows discounted “from” prices alongside regular amounts, multiple powders, and capsule variants. Without a selected package and intended daily intake, the headline cannot provide a reliable monthly cost. Medical-food use calls for its clinical context and supervision; VSL4’s wellness role still needs a clear label and suitability assessment. Neither family is evidence of a substitute for prescription GLP-1 treatment.

Official sources and evidence

Sources checked October 1, 2026. Brand pages document public offers and claims; agency references provide broader evidence and safety context.

  1. VSL Probiotics ↗Official product page · Checked 2026-10-01
  2. NCCIH: Probiotics — Usefulness and Safety ↗Probiotic evidence and safety · Checked 2026-10-01
  3. NIH ODS: Dietary Supplements — What You Need to Know ↗General evidence and safety · Checked 2026-10-01
  4. FDA: Questions and Answers on Dietary Supplements ↗Regulatory guidance · Checked 2026-10-01